Latest Articles
Lexi Young reveals she was hospitalized while filming Joey Graziadei's 'The Bachelor' season - Reality TV World
Lexi Young reveals she was hospitalized while filming Joey Graziadei's 'The Bachelor' season Reality TV World
Published: March 23, 2024, 7 a.m.
An endometrial receptivity scoring system evaluated by ultrasonography in patients undergoing frozen–thawed embryo transfer: a prospective cohort study - Frontiers
An endometrial receptivity scoring system evaluated by ultrasonography in patients undergoing frozen–thawed embryo transfer: a prospective cohort study Frontiers
Published: March 21, 2024, 7 a.m.
Data May Support Pembrolizumab/Chemo as New SOC in Endometrial Cancer - Cancer Network
Data May Support Pembrolizumab/Chemo as New SOC in Endometrial Cancer Cancer Network
Published: March 21, 2024, 7 a.m.
Rucaparib Maintenance Therapy in Recurrent/Metastatic Endometrial Cancer - Oncology Learning Network
Rucaparib Maintenance Therapy in Recurrent/Metastatic Endometrial Cancer Oncology Learning Network
Published: March 21, 2024, 7 a.m.
The Bachelor star reveals she was hospitalised during filming - The Independent
The Bachelor star reveals she was hospitalised during filming The Independent
Published: March 21, 2024, 7 a.m.
Rucaparib Maintenance Boosts PFS in Metastatic, Recurrent Endometrial Cancer - Medpage Today
Rucaparib Maintenance Boosts PFS in Metastatic, Recurrent Endometrial Cancer Medpage Today
Published: March 19, 2024, 7 a.m.
GSK Builds Case for Broader Jemperli Label in Endometrial Cancer with Phase III Data - BioSpace
GSK Builds Case for Broader Jemperli Label in Endometrial Cancer with Phase III Data BioSpace
Published: March 18, 2024, 7 a.m.
AstraZeneca, GSK make case for broad immunotherapy uses in endometrial cancer. But questions remain - FiercePharma
AstraZeneca, GSK make case for broad immunotherapy uses in endometrial cancer. But questions remain FiercePharma
Published: March 18, 2024, 7 a.m.
Trastuzumab Deruxtecan Proves Active in HER2-Expressing Gynecologic Cancers - Cancer Therapy Advisor
Trastuzumab Deruxtecan Proves Active in HER2-Expressing Gynecologic Cancers Cancer Therapy Advisor
Published: March 17, 2024, 7 a.m.
99mTc-maraciclatide holds potential as a non-invasive test for early-stage endometriosis - News-Medical.Net
99mTc-maraciclatide holds potential as a non-invasive test for early-stage endometriosis News-Medical.Net
Published: March 15, 2024, 7 a.m.
Link copied to clipboard!